Umberto Vespasiani-Gentilucci

15PUBLICATIONS
52CO-AUTHORS
Cancer diagnosisMedical molecular engineering of nucleic acids and proteinsEpidemiological modellingMedical biochemistry - lipidsComputational linguistics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 03, 2025
Quality Measures to Enhance the Management and Treatment of Primary Biliary Cholangitis: A Delphi Consensus Study.

Domenico Alvaro, Vincenza Calvaruso, Marco Carbone

|Sep 16, 2024
Integrating PNPLA3 into clinical risk prediction.

Vincent L Chen, Umberto Vespasiani-Gentilucci

|Mar 18, 2024
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population.

Antonio De Vincentis, Federica Tavaglione, Shinichi Namba

|Mar 10, 2024
Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease.

Federica Tavaglione, Valentina Flagiello, Francesca Terracciani

|Sep 18, 2023
Usefulness of PNPLA3 variant for predicting hepatic events in steatotic liver disease: a matter of ethnicity or baseline risk?

Umberto Vespasiani-Gentilucci, Luca Valenti, Stefano Romeo

|Apr 24, 2023
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease.

Rosaria M Pipitone, Francesco Malvestiti, Grazia Pennisi

Pageof 3

Frequent Collaborators

6 joint publications

Stefano Romeo

4 joint publications

Antonio De Vincentis

4 joint publications

Luca Valenti

3 joint publications

Marco Carbone